Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte colony stimulating factor (G-CSF)

Journal of Controlled Release

Volumn 52, Issue 1-2, 1998, Pages 131-139

  Gibaud, S ^a   Rousseau, C ^b   Weingarten, C ^a   Favier, R ^c   Douay, L ^c   Andreux, J P ^b   Couvreur, P ^a  

^a Pharmacotech Biopharm URA C   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Cyanoacrylates; Drug carriers; Granulocyte colony stimulating factor (G CSF); Nanoparticles

Indexed keywords

CYANOACRYLATE; DRUG CARRIER; ETHYL CELLULOSE; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NEUTROPENIA; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CYANOACRYLATES; DRUG CARRIERS; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; MICE;

EID: 0032473463     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00194-6     Document Type: Article

References (21)

1. Nicola N.A., Metcalf D., Matsumoto M., Johnson G.R. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. J. Biol. Chem. 258(14):1983;9017-9023.
2. Nomura H., Imazeki I., Oheda M., Kubota N., Tamura M., Ono M., Ueyama Y., Asano S. Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 5:1986;871-876.
3. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H., Ono M. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature. 319:1986;415-418.
4. Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A., Mertelsmann R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 232:1986;61-65.
5. Tanaka H., Okada Y., Kawagishi M., Tokiwa T. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat. J. Pharmacol. Exp. Ther. 251(3):1989;1199-1203.
6. Watanabe Y., Matsumoto Y., Kikuchi R., Kiriyama M., Nakagawa K., Nomura H., Maruyama K., Matsumoto M. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) following intranasal administration in rabbits. J. Drug Target. 3:1995;231-238.
7. Meyer J., Whitcomb L., Treuheit M., Collins D. Sustained in vivo activity of recombinant human granulocyte colony stimulating factor (rHG-CSF) incorporated into hyaluronan. J. Control. Rel. 35:1995;67-72.
8. Knüsli C., Delgado C., Malik F., Dòmine M., Tejedor M.C. Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activity. Br. J. Haematol. 82:1992;654-663.
9. Meyer J., Whitcomb L., Collins D. Efficient encapsulation of proteins within liposomes for slow release in vivo. Biochem. Biophys. Res. Commun. 199(2):1994;433-438.
10. Gibaud S., Andreux J.P., Weingarten C., Renard M., Couvreur P. Increased bone marrow toxicity of doxorubicin bound to nanoparticles. Eur. J. Cancer. 30A(6):1994;820-826.
11. Gibaud S., Demoy M., Andreux J.P., Weingarten C., Gouritin B., Couvreur P. Cells involved in the capture of nanoparticles in hematopoietic organs. J. Pharm. Sci. 85(9):1996;944-950.
12. Couvreur P., Kante B., Roland M., Guiot P., Baudouin P., Speiser P. Polyalkylcyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31:1979;331-332.
13. H. Fessi, J.P. Devissaguet, F. Puisieux, C. Thies, Procédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanoparticules, French Patent; 2 608 988; 1988.
14. Olivier J.C., Taverna M., Vauthier C., Couvreur P., Baylocq-Ferrier D. Capillary electrophoresis monitoring of the competitive adsorption of albumin onto the orosomucoid-coated polyisobutylcyanoacrylate nanoparticles. Electrophoresis. 15:1994;234-239.
15. Iscove N.N., Sieber S. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp. Hematol. 3:1975;32-43.
16. Grangier J.L., Puygrenier M., Gautier J.C., Couvreur P. Nanoparticles as carriers for growth hormone releasing factor. J. Control. Rel. 15:1991;3-13.
17. Tseng Y.C., Hyon S.H., Ikada Y. Modification of synthesis and investigation of properties for 2-cyanoacrylates. Biomaterials. 11:1990;73-79.
18. Lu H.S., Clogston C.L., Narhi L.O., Merewether L.A., Pearl W.R., Boone T.C. Folding and oxidation of recombinant human granulocyte colony stimulating factor produced in Escherichia coli. J. Biol. Chem. 267(13):1992;8770-8777.
19. Müller R.H., Lherm C., Herbort J., Blunk T., Couvreur P. Alkylcyanoacrylate drug carriers: I.Physicochemical characterization of nanoparticles with different alkyl chain length. Int. J. Pharm. 84:1992;1-11.
20. Lenaerts V., Couvreur P., Christiaens-Leyh D., Joiris E., Roland M., Rollman B., Speiser P. Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials. 5:1984;65-68.
21. Grislain L., Couvreur P., Lenaerts V., Roland M., Deprez-Decampeneere D., Speiser P. Pharmacokinetics and distribution of biodegradable drug-carriers. Int. J. Pharm. 15:1983;335-345.